Low-dose aspirin is not an alternative to any other treatment. Patients with cancer should however raise the topic of aspirin with their healthcare team and enquire whether or not low-dose aspirin is likely to be helpful to them.
by The Welsh Aspirin Group Peter Elwood, Gareth Morgan, Richard Adams, Christine Delon, Marcus Longley, Simon Noble, Janet Pickering, Majd Protty, John Watkins, Anna Yeatman Corresponding author: Gareth Morgan ABSTRACT: Aspirin is a remarkable drug Read more
Myeloproliferative neoplasms (MPN’s) are a group of blood cancers. MPN’s are bone marrow disorders which results in an excess of blood cells. As a result, these blood cancers are associated with risks of clots and Read more
Abstract There is a growing body of evidence that aspirin could be helpful in the treatment of cancer. In this paper, ten randomised controlled trials are reviewed covering more than 8,000 patients with several different Read more
An abstract by Dr Gareth Morgan, John Watkins, Majad Protty and Professor Peter Elwood Click image for link to the article.
There are four basic ethical principles in clinical practice: non-maleficence; beneficence; autonomy and justice. Evidence upon which each of these is judged comes from appropriate research, but there are also personal opinions and claims – Read more